Michael Sey

Michael Sey

Auto-generated profile, based on publicly available information

Michael Sey

Division of Gastroenterology, Western University, Canada; Lawson Health Research Institute, London Health Sciences Centre, Canada; Department of Epidemiology and Biostatistics, Western University, Canada

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MAMajed Almaghrabi
Majed Almaghrabi
MGMandark Gandhi
Mandark Gandhi
LGLeonardo Guizzetti
Leonardo Guizzetti
AIAlla Iansavichene
Alla Iansavichene
BYBrian Yan
Brian Yan
MSMichael Sey
Michael Sey
Lower gastrointestinal bleeding (LGIB) is a common reason for emergency hospitalization, with an annual incidence rate upward of 87 cases per 100 000 individuals.1-4 Most often, LGIB is a self-limiting condition, with most cases resolving spontaneously.1,5 However, major bleeding resulting in blood transfusion, surgery, and even death can occur in some cases. In a large, prospective cohort study involving 2528 cases of LGIB across 143 hospitals, 26.3% of patients required blood transfusion, 1% required embolization or surgery, and 3.4% died.5 On a population level, LGIB is expensive and imposes considerable costs on the health care system, largely owing to hospitalizations. In a registry study of 30 498 hospitalized patients with gastrointestinal bleeding, those with LGIB had longer lengths of stay (mean [SD], 13.9 [8.8] days vs 11.6 [7.9] days) and higher resource use than patients with upper gastrointestinal bleeding.2

31 May 2011 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Open access
MSMichael Sai Lai Sey
Michael Sai Lai Sey
JPJeremy Parfitt
Jeremy Parfitt
JGJamie Gregor
Jamie Gregor
Background: Pure oats are safe for most patients with celiac disease, but concerns regarding contamination by other grains limit their consumption. The Canadian Celiac Association recently released guidelines governing the production of pure oats. The objective was to test the safety of a product manufactured under these guidelines. Methods: Fifteen adults with established, biopsy‐confirmed celiac disease of ≥1 year duration were challenged with 350 g/wk of pure oats for 12 weeks. Symptom scores, weight, hemoglobin, ferritin, albumin, and tissue transglutaminase (tTG) were assessed at weeks 0, 6, and 12. Duodenal biopsies were obtained before and after oat challenge and assessed based on the modified Marsh–Oberhuber score. Compliance with a gluten‐free diet was monitored with random food diaries. Results: Fifteen patients completed the study and were analyzed in intention‐to‐treat and per‐protocol analyses. There were no significant changes in symptom scores, weight, hemoglobin, ferritin, or albumin during oat consumption. The tTG remained negative in all patients, and the histology scores did not significantly change during oat challenge. The only relapse occurred in a patient who became noncompliant with her gluten‐free diet. Conclusion: The findings support the safety of pure, uncontaminated oats manufactured under Canadian Celiac Association guidelines for patients with celiac disease.

25 February 2019 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
OKomar kherad
omar kherad
SRSophie Restellini
Sophie Restellini
MMMyriam Martel
Myriam Martel
MSMichael Sey
Michael Sey
MMMichael F. Murphy
Michael F. Murphy
VJVipul Jairath
Vipul Jairath
Background Restrictive red blood cell (RBC) transfusion reduces mortality and rebleeding after upper gastrointestinal bleeding (UGIB). However, there is no evidence to guide transfusion strategies in lower gastrointestinal bleeding (LGIB). Aim To assess the association between RBC transfusion strategies and outcomes in patients with LGIB Methods This was a post hoc analysis of the UK National Comparative Audit of LGIB and the Use of Blood. The relationships between liberal RBC transfusion and clinical outcomes of rebleeding, mortality and a composite outcome for safe discharge were examined. Transfusion strategy was dichotomised and defined as “liberal” when transfusion was administered for haemoglobin (Hb) ≥80 g/L (or ≥90 g/L in patients with acute coronary syndrome) or major haemorrhage, and “restrictive” otherwise. Multivariable logistic regression models were used to assess the independent association between liberal RBC transfusion and outcomes. Results Of 2528 consecutive patients enrolled from 143 hospitals in the original study, 666 (26.3%) received RBC transfusion (mean age 73.3 ± 16 years, 49% female, initial mean haemoglobin 90 ± 24 g/L, 2.3% had haemodynamic instability). The rebleeding rate in transfused patients was 42.3%. After adjusting for potential confounders, there was no difference between liberal and restrictive RBC transfusion strategies for the odds of rebleeding (OR 0.89, 95% CI 0.6‐1.22), in‐hospital mortality (OR 0.54, 95% CI 0.3‐1.1) or of achieving the composite outcome (OR 0.72, 95% CI 0.5‐1.1). Conclusion Although these results could be due to residual confounding, they provide an important foundation for the design of randomised trials to evaluate transfusion strategies for LGIB.

24 October 2014 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
MSMichael S. L. Sey
Michael S. L. Sey
LSLeslie Schmaltz
Leslie Schmaltz
MAMohammad A. Al-Haddad
Mohammad A. Al-Haddad
JDJohn M. DeWitt
John M. DeWitt
CCCynthia S. J. Calley
Cynthia S. J. Calley
JLJulia K. LeBlanc
Julia K. LeBlanc
Background and study aims: Endoscopic ultrasound – guided celiac plexus block (EUS-CPB) is an established treatment for pain in patients with chronic pancreatitis (CP), but the effectiveness and safety of repeated procedures are unknown. Our objective is to report our experience of repeated EUS-CPB procedures within a single patient. Patients and methods: A prospectively maintained EUS database was retrospectively analyzed to identify patients who had undergone more than one EUS-CPB procedure over a 17-year period. The main outcome measures included number of EUS-CPB procedures for each patient, self-reported pain relief, duration of pain relief, and procedure-related adverse events. Results: A total of 248 patients underwent more than one EUS-CPB procedure and were included in our study. Patients with known or suspected CP (N = 248) underwent a mean (SD) of 3.1 (1.6) EUS-CPB procedures. In 76 % of the patients with CP, the median (range) duration of the response to the first EUS-CPB procedure was 10 (1 – 54) weeks. Lack of pain relief after the initial EUS-CPB was associated with failure of the next EUS-CPB (OR 0.17, 95 %CI 0.06 – 0.54). Older age at first EUS-CPB and pain relief after the first EUS-CPB were significantly associated with pain relief after subsequent blocks (P = 0.026 and P = 0.002, respectively). Adverse events included peri-procedural hypoxia (n = 2) and hypotension (n = 1) and post-procedural orthostasis (n = 2) and diarrhea (n = 4). No major adverse events occurred. Conclusions: Repeated EUS-CPB procedures in a single patient appear to be safe. Response to the first EUS-CPB is associated with response to subsequent blocks.

23 June 2017 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
MSMichael Sey
Michael Sey
ALAndy Liu
Andy Liu
SASamuel Asfaha
Samuel Asfaha
VSVictoria Siebring
Victoria Siebring
VJVipul Jairath
Vipul Jairath
BYBrian Yan
Brian Yan
Background and study aims Adenoma detection rate (ADR) is an important measure of colonoscopy quality, as are polyp, advanced ADR, and adenocarcinoma detection rates. We investigated whether performance report cards improved these outcome measures. Patients and methods Endoscopists were given report cards comparing their detection rates to the institutional mean on an annual basis. Detection rates were evaluated at baseline, 1 year after report cards (Year 1), and 2 years after report cards (Year 2). Endoscopists were unaware of the study and received no other interventions. The primary outcome was ADR and secondary outcomes were polyp detection rate (PDR), advanced ADR, and adenocarcinoma detection rate. Multivariate regression was performed to adjust for temporal trends in patient, endoscopists, and procedural factors. Results Seventeen physicians performed 3,118 screening colonoscopies in patients with positive FOBT or family history of colon cancer. The ADR increased from 34.5 % (baseline) to 39.4 % (Year 1) and 41.2 % (Year 2) (P = 0.0037). The PDR increased from 45 % (baseline) to 48.8 % (Year 1) and 51.8 % (Year 2) (P = 0.011). There was no significant improvement in advanced ADR or adenocarcinoma detection rates. On multivariate analysis, the ADR increased by 22 % in Year 1 (P = 0.03) and 30 % in Year 2 (P = 0.008). Among physicians with a baseline ADR < 25 %, improvement in ADR was even greater, increasing 2.2 times by the end of the study (P = 0.004). Improvements in ADR were not correlated with specialty although gastroenterologists were 52 % more likely to find an adenoma than general surgeons. Conclusions Annual performance report cards increased adenoma detection rates, especially among physicians with low ADR < 25 %.

9 January 2019 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
MSMichael Sai Lai Sey
Michael Sai Lai Sey
SMSeid B. Mohammed
Seid B. Mohammed
MBMayur Brahmania
Mayur Brahmania
SSSiddharth Singh
Siddharth Singh
BKBrennan C. Kahan
Brennan C. Kahan
VJVipul Jairath
Vipul Jairath
Summary: Background: Outcomes after Nonvariceal upper gastrointestinal bleeding (NVUGIB) have historically focused on ulcer‐related causes. Little is known regarding non‐ulcer bleeding, the most common cause of NVUGIB.Aim: To compare outcomes between ulcer‐ and non‐ulcer‐related NVUGIB and explore whether these could be explained by differences in baseline characteristics, bleeding severity or processes of care.Methods: Analysis of 4474 patients with NVUGIB from 212 United Kingdom hospitals as part of a nationwide audit. Logistic regression models were used to adjust for baseline characteristics, bleeding severity and processes of care.Results: 1682 patients had ulcer‐related and 2792 patients had non‐ulcer‐related bleeding. Those with ulcer‐related bleeding were older (median age 73 vs 69, P < 0.001), less likely to have been taking a PPI (18% vs 32%, P < 0.001), more likely to have been taking aspirin (40% vs 27%, P < 0.001) and present with shock (43% vs 32%, P < 0.001). Furthermore, those with ulcer‐related bleeding were more likely to receive blood transfusion (66% vs 39%, P < 0.001), PPI infusion (27% vs 5%, P < 0.001) and endoscopic therapy (37% vs 8%, P < 0.001). Overall, ulcer‐related bleeding had higher odds of in‐hospital mortality (OR: 1.54; 95% CI: 1.21‐1.96, P < 0.0001), rebleeding (OR: 2.08; 95% CI: 1.73‐2.51, P < 0.0001) and need for surgical/radiologic intervention (OR: 2.64; 95% CI: 1.85‐3.77, P < 0.0001). The associations disappeared after adjustment for bleeding severity, whereas adjustment for patient characteristics or process of care factors had no impact.Conclusion: Patients with ulcer‐related NVUGIB bleeding have worse outcomes than those with non‐ulcer‐related NVUGIB bleeding, which is due to more severe bleeding.